Anti-Human sRANKL (Serum) – RF0096


  • Description: Rabbit Polyclonal Antibody Serum to sRANKL
  • Application: WB, ELISA
  • Reactivity: Human
  • Conjugate: Unconjugated
Download datasheet

Product options

Clear selection


Description: Anti-Human sRANKL Serum is developed in rabbit using recombinant sRANKL produced in plants.

Immunogen: Highly pure (>97%) recombinant human sRANKL expressed in plants.


  • ELISA: Suggested starting dilution 1/4,000. This antibody, in conjunction with compatible secondary reagent (anti-rabbit IgG-AP conjugate), allows the detection of > 0,5 ng/well of rhuman sRANKL (RF0038)
  • Western Blot: Suggested starting dilution 1/4,000. Anti-rabbit IgG-AP (alkaline phosphatase conjugate) is recommended as secondary reagent.
 RF0096.-WB-Anti-Human sRANKL Serum
Fig 1. Western Blot analysis of rhuman sRANKL using Anti-Human sRANKL Serum (RF0096)
Human sRANKL  protein was resolved by SDS-PAGE, transferred to a NC membrane and probed with a dilution 1:4,000 of Anti-Human sRANKL serum. Anti-rabbit IgG-AP (alkaline phosphatase conjugate) was used as secondary reagent. Lane 1: MWM (kDa); Lane 2: 0.5 ug of glycosylated isoforms of rHuman sRANKL protein produced in an eukaryotic expression system. Lane 3: 0.1 ug of non glycosylated  rHuman sRANKL protein produced in a prokaryotic expression system.

Where this antibody has not been tested for use in a particular technique this not necessarily excludes its use in such procedures.

Optimal dilution conditions should be determined by the final user.
Bulk sizes are available upon request. For R&D purposes only.
Purchaser must determine the suitability of the product(s) for their particular use.